Skip to main content
Premium Trial:

Request an Annual Quote

MDxK to Distribute Halo Genomics Products in South Korea


Halo Genomics has added MDxK as distributor of its sequencing target enrichment products in South Korea, the company said last week.

Halo Genomics, based in Uppsala, Sweden, offers sequencing target selection services and kits that are based on its Selector technology. It is currently working on a new product, the HaloPlex Target Enrichment kit, that combines single-tube target amplification and sequencing library prep for the Illumina platform (IS 3/1/2011).

The firm, which changed its name from Olink Genomics last year, recently signed on a number of other distributors: Westburg for Belgium, Luxembourg, and the Netherlands; Cambio for the UK; Integrated Sciences for Australia and New Zealand; and Biozym Scientific for Germany and Austria.

MdxK, founded in 2007 and based in Seoul, provides products and services for molecular research and diagnostics in South Korea.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.